Sumatriptan Succinate Injection
Product Images NDC 55111-693

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 55111-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Autoinjector (Autoinjector)

Sumatriptan Injection USP 6 mg/0.5 mL autoinjector system label from Dr. Reddy's Laboratories Limited. The label includes step-by-step directions for subcutaneous injection with images demonstrating use. It indicates the product is a single-dose autoinjector for subcutaneous use, with storage instructions, manufacturer information in India, and regulatory details including NDC 55111-693 and barcode.*

FDA Label Image

Carton (Carton)

Packaging label for Sumatriptan Injection USP autoinjector system, 6 mg/0.5 mL strength. Contains 2 prefilled 0.5 mL syringes for subcutaneous injection. Label includes step-by-step instructions for use, product warnings, storage instructions, and manufacturer Dr. Reddy's Laboratories Limited. The label features barcodes, product NDC 55111-693, and emphasizes that it is for human prescription use only.*

FDA Label Image

Fig (Fig)

A line graph comparing the estimated percentage of subjects with relief over time (0 to 25 minutes) for Sumatriptan versus placebo. The x-axis represents time in minutes and the y-axis shows the estimated percentage of subjects with relief. The graph shows two lines: one for Sumatriptan (N=131) with a higher percentage of subjects experiencing relief over time, and one for placebo (N=127) with a lower percentage.*

FDA Label Image

Fig1 (Fig1)

Sumatriptan Injection USP 6 mg/0.5 mL autoinjector for subcutaneous injection by Dr. Reddy's Laboratories Limited. The image shows a single-dose autoinjector pen with a blue cap and a white body featuring usage instructions on the label. The label includes product name, strength, and step-by-step injection directions.*

FDA Label Image

Fig10 (Fig10)

Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection pen by Dr. Reddy's Laboratories Limited. The image shows hands pulling off the blue cap of the injection pen, revealing the label with product information and usage instructions.*

FDA Label Image

Fig11 (Fig11)

An instructional image showing hands holding a Sumatriptan Succinate injection pen with the cap removed, demonstrating the direction to close the cap by sliding it onto the injection pen. The product label indicates Sumatriptan Injection USP 6 mg/0.5 mL by Dr. Reddy's Laboratories Limited for subcutaneous use.*

FDA Label Image

Fig2 (Fig2)

An instructional diagram showing parts of the Sumatriptan Injection USP 6 mg/0.5 mL autoinjector pen by Dr. Reddy's Laboratories Limited. The pen features a blue cap, a medicine window to check liquid clarity, and a button that must be pressed firmly to start the injection. Labels identify each part and describe its function.*

FDA Label Image

Fig3 (Fig3)

Illustrations showing two methods for subcutaneous injection of Sumatriptan Succinate injection 6 mg/.5 mL. One image demonstrates injecting into the thigh area, and the other shows injection into the arm. Each image features a person holding an auto-injector syringe for administration.*

FDA Label Image

Fig4 (Fig4)

An illustration showing a partial view of a device or injector with a blue protective cap and a small window displaying a clear liquid inside. The image includes a label pointing to the window, indicating the presence of the clear liquid.*

FDA Label Image

Fig5 (Fig5)

An instructional illustration showing a close-up of a sumatriptan injection device with a visible needle. An arrow points to the needle tip, highlighting its presence within the device, which is primarily white with a blue cap.*

FDA Label Image

Fig6 (Fig6)

An illustration showing two blue cylindrical caps with a partial view inside demonstrating correct and incorrect positioning. The left cap, marked with a check symbol, encloses a gray syringe inner part properly, while the right cap, marked with an X, is empty, indicating incorrect placement or usage.*

FDA Label Image

Fig7 (Fig7)

An instructional illustration showing the correct 90-degree angle injection technique for Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection. The image depicts a hand holding the prefilled syringe above the skin with an arrow emphasizing the straight downward injection angle. A close-up inset highlights the needle positioning at the skin surface before injection.*

FDA Label Image

Fig8 (Fig8)

An instructional illustration showing a hand holding a Sumatriptan Succinate 6 mg/0.5 mL subcutaneous injection device, positioned for administration. The image features a speech bubble with "CLICK" and an arrow indicating to press down on the device for use.*

FDA Label Image

Fig9 (Fig9)

Instructional image showing proper use of a Sumatriptan Succinate subcutaneous injection pen. The left panel depicts pressing the pen against the skin for 5 seconds until a click sound is heard. The right panel illustrates removing the pen from the skin after injection, indicated by an upward arrow and accompanying text.*

FDA Label Image

Stru (Stru)

Chemical structure of Sumatriptan Succinate, showing the molecular arrangement of sumatriptan combined with succinate.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.